Celator Pharmaceuticals is now a subsidiary of Jazz Pharmaceuticals plc. Read more.
The companies share a focus on improving patients' lives and addressing unmet medical needs.
The combined team will build on the innovative development of Celator’s investigational pipeline and on Jazz’s proven expertise in hematology/oncology.
To learn more about Jazz Pharmaceuticals, please visit www.JazzPharmaceuticals.com.
For Medical Information Requests related to Celator investigational products click here.
For Adverse Events/Drug Complaints related to Celator investigational products click here.
Clinical sites may report adverse events by Fax to 609.243.0202.
General Contacts: https://www.jazzpharma.com/contact/